Introduction: Clear cell renal cell carcinoma (ccRCC), representing 75-80% of RCC cases, is frequently associated with inactivation or mutation of the von Hippel-Lindau (VHL) tumor suppressor gene (1). Disruption of VHL function upregulates hypoxia-inducible factor (HIF) pathways, driving tumorigenesis. Current frontline treatments for advanced ccR
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2385 Reached7 Comments4 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes